Coming soon to an ECP near you: Cheaper Lipiflow?
Seems probable...
MORRISVILLE, N.C.--10/28/15 - (BUSINESS WIRE)--TearScience, a privately held medical device company, has announced a 50% price cut, effective immediately, on the single-use activators used with the LipiFlow treatment platform for Meibomian Gland Disease (MGD). The move is just one component of an overall strategy to make the LipiFlow and LipiView® Technologies more accessible to Eye Care Professionals (ECPs), who can then, in turn, use them to evaluate and intervene earlier in MGD for the benefit of the millions of individuals suffering from this chronic and progressive obstructive gland disease.
After recent unprecedented growth in use of its LipiFlow technology, TearScience is achieving the economies of scale necessary to reorganize and expand its supply and manufacturing capabilities. Furthermore, TearScience brought on board a new management team with a renewed mission to meet a market need of technology and treatment accessibility. Earlier this year, TearScience lowered the price of its technologies and removed imaging fees....
2 comments:
Such a great post about the human health. Love it. we all knows that eyes is the most important part of the human body. without the eyes we cannot saw the whole universe. now if you have any type of eye problem you can choose the best clinics across the india at Clinic by Choice website. Just search for the best clinic and choose the best eye surgeon. visit here: Eye Treatment in India
Just came across this post - although it is just over a year ago It still taking time for the changes to trickle down to the street - its is a very dear treatment which is a shame as it is really very effective.
Post a Comment